[ Pobierz całość w formacie PDF ]

OPG and PTH-(1-34) have additive effects on bone density and mechanic strength in osteopenic ovariectomized
rats. Endocrinology 2001, 142, 4295 4304.
[31] ANDERSON D. M., MARASKOVSKY E., BILLINGSLEY W. L., DOUGALL W. C., TOMETSKO M. E., ROUX E. R., TEEPE
M. C., DUBOSE R. F., COSMAN D., GALIBERT L.: A homologue of the TNF receptor and its ligand enhance T-cell
growth and dendritic-cell function. Nature. 1997, 390, 175 179.
[32] HOFBAUER L. C., KHOSLA S., DUNSTAN C. R., LACEY D. L., SPELSBERG T. C., RIGGS B. L.: Estrogen stimulates
gene expression and protein production of of osteoprotegerin in human osteoblastic cells. Endocrinology 1999,
140, 4367 4370.
[33] HOFBAUER L. C., KHOSLA S., DUNSTAN C. R., LACEY D. L., BOYLE W. J., RIGGS B. L: The roles of osteoprotege-
rin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 2000, 15, 2 12.
[34] GROENEVELD M. C., EVERTS V., BEERTSEN W.: Alkaline phosphatase activity in the periodontal ligament and gin-
giva of the rat molar: its relation to cementum formation. J. Dent. Res. 1995, 74, 1374 1381.
[35] TSUDA E., GOTO M., MOCHIZUKI S., YANO K., KOBAYASHI F., MORINAGA T., HIGASHIO K.: Isolation of a novel cy-
tokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun.
1997, 234, 137 142.
[36] GINIGER M. S., NORTON L., SOUSA S., LORENZO J. A., BRONNER F.: A human periodontal ligament fibroblast
clone releases a bone resorption inhibition factor in vitro. J. Dent. Res. 1991, 70, 2, 99 101.
[37] WU Y. M., RICHARDS D. W., ROWE D. J.: Production of matrix-degrading enzymes and inhibition of osteoclast-like
cell differentiation by fibroblast-like cells from the periodontal ligament of human primary teeth. J. Dent. Res.
1999, 78, 681 689.
Molekularne procesy resorpcji kości
635
[38] WADA N., MAEDA H., TANABE K., TSUDA E., YANO K., NAKAMUTA H., Akamine A.: Periodontal ligament cells se-
crete the factor that inhibits osteoclastic differentition and function: the factor is osteoprotegerin/osteoclastogene-
sis inhibitory factor. J. Periodontal Res. 2001, 36, 56 63.
[39] SAKATA M., SHIBA M., KOMATSUZAWA H.: Expression of osteoprotegerin in cultures of human detal mesenchymal
stem cells and epithelial cells. J. Bone Miner. Res. 1999, 14, 1486 1492.
[40] HASEGAWA T., YOSHIMURA Y., KIKUIRI T., YAWAKA Y., TAKEYAMA S., MATSUMOTO A., OGUCHI H., SHIRAKAWA T.:
Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal liga-
ment cells. J. Periodontal Res. 2002, 37, 405 411.
[41] KANZAKI H., CHIBA M., SHIMZU Y., MITANI H.: Dual regulation of osteoclast differentiation by periodontal liga-
ment cells through RANKL stimulation and OPG inhibition. J. Dent. Res. 2001, 80, 887 891.
[42] CROTTI T., SMITH M. D., HIRSCH R., SOUKOULIS S., WEEDON H., CAPONE M., AHERN M. J., HAYNES D.: Receptor
activator NF-kappa B ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J. Perio-
dontal Res. 2003, 38, 380 387.
[43] KONG Y. Y., PENNINGER J. M.: Molecular control of bone remodeling and osteoporosis. Exp. Gerontol. 2000, 35,
947 956.
[44] GEMMELL E., MARSHALL R. I., SEYMOUR G. J.: Cytokines and prostaglandins in immune homeostasis and tissue
destruction in periodontal disease. Periodontology 2000, 1997, 14, 112 143.
[45] TENG Y.-T. A., NGUYEN H., GAO X., KONG Y., GORCZYNSKI R. M., SINGH B., ELLEN R. P., PENNINGER J.M.: Func-
tional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infec-
tion. J. Clin. Invest. 2000, 106, R59 R67.
[46] BAKER P. J., HOWE L., GARNEAU J., ROOPENIAN D. C.: T cell knockout mice have diminished alveolar bone loss
after oral infection with Porphyromonas gingivalis. FEMS Immunol. Med. Microbiol. 2002, 34, 45 50.
[47] REDLICH K., HAYER S., MAIER A., DUNSTAN C. R., TOHIDAST-AKRAD M., LANG S., TURK B., PIETSCHMANN P., WO-
LOSZCZUK W., HARALAMBOUS S., KOLLIAS G., STEINER G., SMOLEN J. S., SCHETT G.: Tumor necrosis factor alpha-
mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 2002, 46,
785 792.
[48] LIU D., XU J. K., FIGLIOMENI L., HUANG L., PAVLOS N. J., ROGERS M., TAN A., PRICE P., ZHENG M. H.: Expression
of RANKL and OPG mRNA in periodontal disease possible involvement in bone destruction. Int. J. Mol. Med.
2003, 11, 17 21.
[49] MOGI M., OTOGOTO J., OTA N., TOGARI A.: Differential expression of RANKL and osteoprotegerin in gingival cre-
vicular fluid of patients with periodontitis. J. Dent. Res. 2004, 83, 166 169.
[50] WA
ODARSKI K., KOCHANOWSKA I., PIEC
KOWSKI M., OSTROWSKI K.: Influence of osteoprotegerin (OPG) on expe-
rimentally induced ectopic bone. Folia Biol. (Kraków) 2004, 52, 205 209.
[51] BEKKER P. J., HOLLOWAY D., NAKANISHI A., ARRIGHI M., LEESE P. T., DUNSTAN C. R.: The effect of a single dose
of osteoprotegerin in postmenopausal women. J. Bone Miner. Res. 2001, 16, 348 360.
[52] BATEMAN T. A., COUNTRYMAN S.: Osteoprotegerin and bone loss associated with spaceflight. Drug Discov. Today
2002, 7, 456 457.
[53] POCHWALSKI M., URBANOWSKA E., WOJTOWICZ A.: Inżynieria tkankowa: Zastosowania w stomatologii: masa płyt-
kowa. Cz.1. Nowa Stomat. 2000, 5, 1, 7 12.
[54] NAKASHIMA T., WADA T., PENNINGER J. M.: RANKL and RANK as a novel therapeutic agents for arthritis. Curr.
Opin. Rheumatol. 2003, 15, 280 287.
[55] SENIOR K.: Vaccinating against bone destruction. Drug Discov. Today 2001, 6, 1243 1244.
[56] CHENG X., KINOSAKI M., TAKAMI M., CHOI Y., ZHANG H., MURALI R.: Disabling of receptor activator of nuclear
factor-kappa B (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo.
J Biol Chem. 2004, 279, 8269 8277.
[57] BEKKER P. J., HOLLOWAY D. L., RASMUSSEN A. S., MURPHY R., MARTIN S. W., LEESE P. T., HOLMES G. B., DUN-
STAN C. R., DEPAOLI A. M.: A single-dose placebo-controlled study of AMG 162, a fully human monoclonal an-
tibody to RANKL, in postmenopausal women. J. Bone Miner. Res. 2004, 19, 1059 1066.
[58] SHEVDE N. K., BENDIXEN A. C., DIENGER K. M., PIKE J. W.: Estrogens suppress RANK ligand-induced osteoclast
differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc. Natl. Acad. Sci. USA
2000, 97, 7829 7834.
Adres do korespondencji:
Natalia Stawińska
Katedra i Zakład Periodontologii AM
ul. Krakowska 26
50-425 Wrocław
tel.: + 48 071 78 40 383
Praca wpłynęła do Redakcji: 5.07.2005 r. Received: 5.07.2005
Po recenzji: 9.08.2005 r. Revised: 9.08.2005
Zaakceptowano do druku: 28.09.2005 r. Accepted: 28.09.2005 [ Pobierz całość w formacie PDF ]